Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AltrixBio Inc. logo — LuCI™ — a Novel Drug Platform targeting Metabolic Diseases i...

AltrixBio Inc.

LuCI™ — a Novel Drug Platform targeting Metabolic Diseases in the Gastrointestinal Tract

Founded 2019 United States Cambridge, United States 4 employees Angel Total: $40.00K Biotechnology, Pharmaceutical

General Information

Company Name AltrixBio Inc.
Founded Year 2019
Location United States Cambridge, United States +1
Employees 4
Industries Biotechnology, Pharmaceutical
Funding Stage Angel
Social

Get notified when AltrixBio Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AltrixBio Inc.

AltrixBio is a biotechnology and pharmaceutical startup founded in 2019 in the United States. The company's slogan, "LuCI™ — a Novel Drug Platform targeting Metabolic Diseases in the Gastrointestinal Tract," encapsulates its mission to transform the treatment of cardiometabolic disease. AltrixBio is focused on advancing LuCI™ AJN 003, an oral drug designed to replicate the metabolic success of bariatric surgery in the treatment of Type 2 Diabetes. The company recently secured a $30.00K Angel Round investment on 06 April 2023, with Arizona Technology Investors backing their innovative approach. AltrixBio's pursuit of innovative solutions in metabolic diseases makes it a potential game-changer in the field of biotechnology and pharmaceuticals.

Taxonomy: drug development, therapeutic drugs, metabolic diseases, gastrointestinal targeting, bariatric surgery, Type 2 Diabetes treatment, cardiometabolic disease, oral drug, Duodenal Isolation, AltrixBio, LuCI™ AJN 003, startup, investor analysis, medical innovation, biopharmaceutical

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round •••••• 1
Investor
06 Apr 2023
Angel Round •••••• 1
Investor
11 Jan 2022
Seed Round •••••• 4
Investor Investor Investor Investor
01 Jan 2021

AltrixBio Inc. Alternatives & Competitors

AltrixBio Inc. vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
AltrixBio Inc. vs
Congruence Medical Solutions
Congruence Medical Solutions United States

Addressing compelling needs in injectable drug delivery

8 employees
AltrixBio Inc. vs
Forensic Fluids Laboratories
Forensic Fluids Laboratories United States

The Oral Fluid Drug Testing Specialists

56 employees
Health Care

FAQ About AltrixBio Inc.

LuCI™ — a Novel Drug Platform targeting Metabolic Diseases in the Gastrointestinal Tract
AltrixBio Inc. was founded in 2019.
AltrixBio Inc. is headquartered in Cambridge, United States.
AltrixBio Inc. operates in the following industries: Biotechnology, Pharmaceutical.
AltrixBio Inc. has approximately 4 employees.
AltrixBio Inc. has completed 3 funding rounds, raising a total of $40.00K. The latest funding stage is Angel.
Top alternatives and competitors to AltrixBio Inc. include Bostal Drug Delivery, Congruence Medical Solutions, Forensic Fluids Laboratories, METiS Pharmaceuticals, MPR - Medical Professionals Reference. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AltrixBio Inc. and Bostal Drug Delivery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AltrixBio Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes